Agenda Item - 2022-11-15 - Number 11.2 - Presentation - Sam Chapman of Healing Advocacy Fund 11 .2
Healing Measure 109
Cj Advocacy Program Overview for
Fund Psilocybin Therapy in Oregon
y n"
4 -
J'
Our Mission : •
,„.
The Healing Advocacy Fund is a 501c3 nonprofit dedicated to -
supporting the thoughtful and effective development, \
implementation, and education of the nation's first regulated \ _
psilocybin therapy program, which Oregon voters passed : ,'�
through Measure 109 in November 2020.
t : -,-, ,ram-
f
Healing `=
CjAdvocacy -4
Fund - _
Measure 109
Recap
c
Oregonians Are Suffering Now, More Than ever
1 . According to a recent survey conducted by CDCs National Center for Health
Statistics and the Census Bureau: At the start of the COVID-19 pandemic, 1 in 5
Americans were experiencing symptoms of clinical anxiety or depression, but
now over a third of Oregonians say they are experiencing symptoms amid the
country's coronavirus pandemic.
2. Here in Oregon, the mental health crisis is even more acute. According to Mental
Health America, Oregon's mental health crisis is the 3rd worst in the country.
Psilocybin Re s e arch
,# MEDICAL SCHOOL
qv 5LIl �.<< DspernmaS PsychhSTANFoR ) = � HARVARD ( r
• Rigorous studies at the leading medical
PURDUE JOHNS HOPKINS Ilk ft
research institutions such as Johns COLLEGE OF YkIggMACT MIDICINI
Hopkins, UCLA, University of Alabama and LICE ALA UNIVERSITY Z M
ALABAMA A7$IRMINGHAM C4LVM8IA'UNIVHBSI-i'Y
MEDICAL CENTER University Up
NYU show that psilocybin works. It is tat,University of tZ
department of
BRISTOL Veterans Affairs LABioMed
uniquely effective in treating depression, Irn.in Bl .7.,.al
rip McLean HOSPITAL 7,1`.'I,Sut
RLam
l
Blum ka
end-of-life anxiety, and addiction. ' Perelman
41; School of Mtdicinr Rcse,rh lnriltu r
Imperial College
• It shows so much promise the FDA London ►� Harbor-UCLA
K��vc:�•s ,w
recently granted it a 'breakthrough co«Vg� Faculty of Medicine
1.ONDON
therapy"designation - meaning that it NHS
Greater Manchester l()1Z61,; I t
����
may demonstrate substantial 0 Utrecht University Mental Health 47"1'
NIi5 Faundatloe Trust
improvement above and beyond what is
currently available.
The Measure
109 GOAL: Create licensing and
IN'l : regulatory framework to serve
A measured those who seek Psilocybin
Therapy and could safely benefit
approach from it.
What Measure 109 Does
• Establishes aegulatory framework within the Oregon Health Authority (OHA)
that will allow trained practitioners to administer psilocybin services at specially
licensed centers
• Establishes the Oregon Psilocybin Advisory Board, appointed by the Governor
• Imposes a two-year development period before initial licenses are granted
• Requires the establishment of a training and licensure system for psilocybin
facilitators,psilocybin manufacturers, and testing labs
• Requires the establishment of a tracking system for psilocybin products
Psilocybin Services
A Four Step Process to ensure public health
and safety
o
ASSESSMENT /��///'/�
Participants complete 1!
a screening process and
match with a psilocybin
facilitator based on
individual needs and fit.
(lc)
0
INTENTION-SETTING
Facilitator meets with
0 The Oregon Model participant for a preparation
session to explain the
delivers psilocybin process,incorporate
INTEGRATION SESSION services in a participant goals and
develop an individualized
Participant meets with four-step process safety plan.
their facilitator to integrate
insights and learning from i jithe psilocybin experience
into doily life. 0 0 0
0
ADMINISTRATION SESSION
410 Ps€locybin is administered at
a licensed service center by a
trained facilitator,who oversees
the session and supports the
participant throughout.
• Retail sales
• Off-site consumption, possession,
M 10 9 doe s or production
• Unregulated or untracked
NO T a lb v : psilocybin production, delivery, or
inventory
• Service centers near schools
• Access for minors
Implementation
Overview
• Measure 109 establishes an initialo-year development period.
• During that period,the Oregon Health Authority,with the guidance of an Advisory Board,will
study psilocybin research and science and develop a regulatory program,including rules, training
requirements, and licensing requirements.
• In January 2023,at the completion of the two-year study period, OHAwill begin accepting
applications and issuing licenses to:
o Facilitate psilocybin service administration sessions,
o manufacture psilocybin products,
o operate psilocybin service centers
o test psilocybin products
Implementation Timeline
Feb. 2021
Governor June 2022
makes Advisory Board
Jan, 1st. 2020 appointments makes Jan. 2023
Psiloc bin June 2021 OHA be ins
y to Advisory recommendations g
Advisory Board Board Advisory Board for rules and accepting
application reports science regulations license
process closes and research applications
findings
T
Planning Research Rule-Making
Dec. 2020 Jan. 19th 2021 Mar. 2021 July 2021
Psilocybin Legislative Advisory OHA Dec. 2022
Advisory Board session begins Board's first publishes OHA adopts
application meeting psilocybin rules and
process opens science and regulations
research
Local Control
Overview
Measure 109 set a foundation of state rules and regulations for psilocybin progran
licensee 's to operate within cities and counties.
Measure 109 also gives local governments the option to create additional time
place and manner restrictions on Service Centers and Manufacturers. The base
program exists throughout the state unless voters choose to opt-out by local
ordinance on a general election ballot.
Pub lic S a fe ty & Restrictions
Psilocybin service centers can not locate:
• Within an area zoned exclusively for residential use in Cities.
• Within 1,000 feet of a school
Psilocybin manufacturers can not locate:
• Within a residence or mixedse property that includes a residence.
• Within an area zoned for residential use.
Secure Storage
• All psilocybin products shall be secured within a licensed facility in locked storage accessible only to employees of the
licensed facility.
Sales
• Sales or any other transfers of psilocybin must occur inside the licensed premises
On-Site Use Only
• Psilocybin and psilocybin products can only be ingested at licensed service centers.
Support for M109 was broad and statewide
Measure 109
Permits licensed service providers to administer psilocybin-producing
mushroom and fungi products to individuals 21 years of age or older.
• Benton 63.4%
Yes: 1,270,057 55.7% No: 1,008,199 44.3% • Clackamas (52.4%)
P. • Clatsop (54.9%)
1 III all , • Columbia (50.6)
• Curry (50.3%)
• Deschutes (52.6%)
• Hood River (63.2%)
• Jackson (51.1%)
iippig -J040- I /
TTI • Lane (59.9%)
( • Lincoln (57.6%)
• Multnomah (71.2%)
• Tillamook (51.4%)
• Wasco (50.4%1
• Washington (59.1%)
MI • Yamhill (50.1%)
um
40%50%60% 40% 50%60%
Yes No Source:The Oregonian (2020)
Questions ?
Sam Chapman Thank You
Executive Director
Sam@flealingadvocacyfund.org